Stay updated on XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a comprehensive Locations section listing multiple US states, DC, and Canadian provinces. The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedEditorial updates to the Publications section describe automatic population of PubMed references and include a new revision tag (v3.3.2). The previous wording and revision tag (v3.2.0) were removed.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding/operating status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedNo significant additions or deletions were observed in the study record; core information such as eligibility criteria, primary outcomes, and enrollment remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check93 days agoChange Detected- Update to version v3.2.0 and addition of an important government-operating-status notice. - Removal of the Medullary thyroid carcinoma resource from Genetic and Rare Diseases Information Center.SummaryDifference3%

- Check100 days agoChange DetectedUpdated page version to v3.1.0 and added the specific condition term 'Medullary thyroid carcinoma'; several generic regulatory topics were removed, indicating a content scope shift.SummaryDifference0.3%

Stay in the know with updates to XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.